Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry

Leukemia

Volumn 11, Issue 11, 1997, Pages 1909-1914

  Cabezudo, E ^a   Matutes, E ^a   Ramrattan, M ^a   Morilla, R ^a   Catovsky, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukemia; Minimal residual disease; Quantitative flow cytometry

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN BINDING; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

EID: 0030665507     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400835     Document Type: Article

References (7)

1. Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19-25.
2. Keating MJ. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia. Semin Oncol 1990; 17 (Suppl 8): 49-62.
3. Keating MJ, O'Brien S, Robertson L, Huh Y, Kantarjian H, Plunkett W. Chronic lymphocytic leukemia - correlation of response and survival. Leuk Lymphoma 1993; 2: 167-175.
4. Dyer MJ, Hale G, Hayhoe FG, Waldmann H. Effects of Campath-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype. Blood 1989; 73: 1431-1439.
5. Osterborg A, Fassas AS, Anagnostopoulos A, Dyer MJ, Catovsky D, Mellstedt H. Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia. Br J Haematol 1996; 93: 151-153.
6. Michallet M, Corront B, Hollard D, Gratwohl A, Domingo A, Burnett S. Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: report from the European Cooperative Group for bone marrow transplantation (eight cases). Nouv Rev Fr Hematol 1988; 30: 467-470.
7. Khouri IF, Keating MJ, Vriesendorp HM, Reading CL, Przepiorka D, Huh YO, Andersson BS, Van Besien KW, Mehra RC, Giralt SA, Ippoliti C, Marshall M, Thomas MW, O'Brien S, Robertson LE, Deisseroth AB, Champlin RE. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J Clin Oncol 1994; 12: 748-758.